Health Effects and Exposure Science, Pacific Northwest National Laboratory, Richland, WA, 99352, USA.
Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, 72079, USA.
Food Chem Toxicol. 2019 Mar;125:341-353. doi: 10.1016/j.fct.2018.12.013. Epub 2018 Dec 13.
Evaluating the biological significance of human-relevant exposures to environmental estrogens involves assessing the individual and total estrogenicity of endogenous and exogenous estrogens found in serum, for example from biomonitoring studies. We developed a method for this assessment by integrating approaches for (i) measuring total hormone concentrations by mass spectrometry (Fleck et al., 2018), (ii) calculating hormone bioavailable concentrations in serum and, (iii) solving multiple equilibria between estrogenic ligands and receptors, and (iv) quantitatively describing key elements of estrogen potency. The approach was applied to endogenous (E1, E2, E3, E4), environmental (BPA), and dietary Genistein (GEN), Daidzein (DDZ) estrogens measured in the serum of thirty pregnant women. Fractional receptor occupancy (FRO) based estrogenicity was dominated by E1, E2 and E3 (ER-α, 94.4-99.2% (median: 97.3%), ER-β, 82.7-97.7% (median: 92.8%), as was the total response (TR), which included ligand specific differences in recruitment of co-activator proteins (RCA). The median FRO for BPA was at least five orders of magnitude lower than E1, E2 and E3, and three orders of magnitude lower than the fetal derived E4 and GEN and DDZ. BPA contributed less than 1/1000th of the normal daily variability in total serum estrogenicity in this cohort of pregnant women.
评估人类接触环境雌激素的生物学意义涉及评估血清中内源性和外源性雌激素的个体和总雌激素活性,例如通过生物监测研究。我们通过整合以下方法开发了一种评估方法:(i)通过质谱法测量总激素浓度(Fleck 等人,2018 年),(ii)计算血清中激素的生物可用浓度,以及(iii)解决雌激素配体和受体之间的多个平衡,以及(iv)定量描述雌激素效力的关键要素。该方法应用于内源性(E1、E2、E3、E4)、环境(BPA)和饮食大豆异黄酮(GEN)、染料木黄酮(DDZ)雌激素,这些雌激素在 30 名孕妇的血清中进行了测量。基于部分受体占有率(FRO)的雌激素活性主要由 E1、E2 和 E3(ER-α,94.4-99.2%(中位数:97.3%),ER-β,82.7-97.7%(中位数:92.8%)决定,总反应(TR)也是如此,这包括配体特异性募集共激活蛋白(RCA)的差异。BPA 的中位 FRO 至少比 E1、E2 和 E3 低五个数量级,比胎儿衍生的 E4 和 GEN 和 DDZ 低三个数量级。在该队列的孕妇中,BPA 对总血清雌激素活性的正常日变异性的贡献不到千分之一。